Apr 20, 2017 - Nearly 90% of this biotech's sales could be at risk within the next two years.
Apr 19, 2017 - Zacks Market Edge Highlights: Insulet, Incyte, Intuitive Surgical and Edwards Lifesciences
Apr 19, 2017 - Incyte's (INCY) shares were hit by the FDA's complete response letter (CRL) for the company's rheumatoid arthritis drug.
Apr 18, 2017 - The healthcare industry is much more than Obamacare and drug prices as many companies are using new technologies to create breakthroughs in medicine.
Apr 18, 2017 - Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals
Apr 18, 2017 - Drugmakers get denied, Chipotle continues gains, and earnings season gets under way. Investors have remained optimistic ahead of what could be a tumultuous week.
Apr 17, 2017 - Despite a climbing market, these stocks fell. Find out why.
Apr 17, 2017 - Shares of Incyte and Eli Lilly are reeling following the FDA's rejection of their once-daily rheumatoid arthritis pill.
Apr 17, 2017 - The FDA has rejected Eli Lilly and Incyte's application for approval of a potential blockbuster rheumatoid arthritis drug.
Apr 17, 2017 - Just like picking up stocks with strong growth potential, pinpointing toxic stocks and abandoning them at the right time is the key to protect your portfolio from big losses or make profits by short selling them.